The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens

Abstract Background At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the MDR-TB treatment landscape. However, despite their avail...

Full description

Bibliographic Details
Main Authors: Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan, Kwonjune J. Seung
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Infectious Diseases
Subjects:
MDR-TB
Bedaquiline
Delamanid
Safety
Efficacy
Online Access:http://link.springer.com/article/10.1186/s12879-019-4378-4

Internet

http://link.springer.com/article/10.1186/s12879-019-4378-4

Similar Items